Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Pittsburgh › NPI 1225047699
Hospital

Upmc Passavant

Upmc Passavant was paid $5.15M by Medicaid between Jan 2018 and Dec 2024, across 225 billing codes. Its largest line is 99284, emergency room visit (serious) — 41% of everything it billed.

33Billing provider infoUPMC PASSAVANT
PITTSBURGH, PA 15237
33aNPI1225047699assigned 08/05/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$5.15M
24GClaims206,096
24DCodes billed225
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#57 of 154
Median peer was paid$2.82M
This provider vs. median1.8×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$100K$200K$300K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018248$15K
2019179$9K
202021,366$479K
2021101,955$2.52M
202231,995$630K
202332,301$847K
2024incomplete18,052$642K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 41% 15,334 14,892 $2.11M
G0378 Hospital observation service, per hour 8.7% 2,353 888 $446K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 8.3% 4,722 4,598 $430K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 8.0% 2,467 2,386 $410K
74177 Computed tomography, abdomen and pelvis; with contrast material 3.1% 1,175 1,149 $160K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 2.2% 5,717 5,441 $111K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 1.9% 3,456 3,169 $97K
80053 Comprehensive metabolic panel 1.4% 9,204 8,493 $72K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 1.3% 16,469 14,843 $67K
70551 Magnetic resonance imaging, brain; without contrast material <1% 250 245 $51K
71275 Computed tomographic angiography, chest, with contrast material <1% 315 313 $47K
96375 Therapeutic injection; each additional sequential IV push <1% 3,298 2,903 $45K
213 more codes
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 660 $43K
70450 Computed tomography, head or brain; without contrast material <1% 946 $42K
64415 <1% 125 $37K
80050 General health panel <1% 851 $37K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 573 $35K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 279 $34K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 515 $29K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 196 $28K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 137 $28K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 118 $27K
72141 <1% 117 $26K
93975 <1% 280 $26K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 3,628 $26K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 690 $21K
80048 Basic metabolic panel (calcium, ionized) <1% 3,978 $21K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 357 $20K
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 108 $20K
84443 Thyroid stimulating hormone (TSH) <1% 967 $19K
J3490 Unclassified drugs <1% 4,328 $18K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 310 $18K
71046 Radiologic examination, chest; 2 views <1% 1,268 $16K
80061 Lipid panel <1% 1,267 $16K
93971 <1% 298 $16K
71250 <1% 291 $15K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 527 $14K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 99 $14K
G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation <1% 112 $13K
76536 <1% 271 $12K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 307 $12K
84484 <1% 1,817 $11K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 357 $11K
72125 Computed tomography, cervical spine; without contrast material <1% 258 $11K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 27 $11K
71045 Radiologic examination, chest; single view <1% 2,169 $11K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 266 $11K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 215 $11K
83605 <1% 2,026 $11K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 44 $10K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 105 $10K
96361 Intravenous infusion, hydration; each additional hour <1% 826 $9K
85730 <1% 1,948 $9K
83735 <1% 2,062 $9K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 5,945 $8K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 216 $8K
83690 <1% 2,313 $8K
76770 <1% 184 $7K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 845 $7K
85610 <1% 2,920 $7K
83880 <1% 318 $7K
84439 <1% 915 $6K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 226 $6K
82607 <1% 551 $6K
87040 <1% 499 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 967 $6K
72100 <1% 355 $6K
80076 <1% 859 $5K
78815 Positron emission tomography (PET) for limited area imaging <1% 12 $5K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 188 $5K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 831 $5K
93017 <1% 169 $5K
82728 <1% 462 $5K
84702 <1% 534 $5K
86803 <1% 276 $5K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 140 $5K
87086 Culture, bacterial; quantitative colony count, urine <1% 798 $4K
81025 <1% 1,532 $4K
62323 <1% 69 $4K
A9577 Injection, gadobenate dimeglumine (multihance), per ml <1% 1,001 $4K
73610 <1% 267 $4K
85379 <1% 454 $4K
Q3014 Telehealth originating site facility fee <1% 233 $4K
86618 <1% 198 $4K
85027 <1% 967 $3K
J7030 Infusion, normal saline solution , 1000 cc <1% 8,915 $3K
83540 <1% 439 $3K
73564 <1% 194 $3K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 135 $3K
J1170 Injection, hydromorphone, up to 4 mg <1% 6,777 $3K
73630 <1% 365 $3K
72158 <1% 12 $3K
81001 <1% 1,268 $3K
73502 <1% 174 $3K
73030 <1% 235 $2K
87077 <1% 417 $2K
85652 <1% 969 $2K
81003 <1% 968 $2K
82565 <1% 495 $2K
90715 <1% 217 $2K
J1815 Injection, insulin, per 5 units <1% 209 $2K
86140 <1% 889 $2K
84100 <1% 476 $2K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 160 $2K
86038 <1% 157 $2K
74018 <1% 233 $2K
84153 <1% 81 $2K
76830 Ultrasound, transvaginal <1% 59 $2K
73130 <1% 214 $2K
J7120 Ringers lactate infusion, up to 1000 cc <1% 5,452 $2K
93226 <1% 63 $2K
87186 <1% 320 $2K
72110 <1% 93 $2K
83550 <1% 402 $2K
86850 <1% 415 $2K
82043 <1% 219 $2K
82550 <1% 281 $2K
82977 <1% 190 $1K
82746 <1% 128 $1K
73110 <1% 137 $1K
93970 <1% 25 $1K
72040 <1% 101 $1K
Q9957 Injection, perflutren lipid microspheres, per ml <1% 135 $1K
82962 <1% 1,132 $1K
84403 <1% 46 $1K
84703 <1% 247 $1K
82784 <1% 50 $956.93
87070 <1% 285 $939.89
83615 <1% 142 $894.50
72050 <1% 37 $876.35
86901 <1% 427 $834.42
86900 <1% 428 $828.25
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 305 $817.60
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 44 $760.66
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 6,401 $753.23
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 44 $744.74
C9399 Unclassified drugs or biologicals <1% 182 $740.09
J0690 Injection, cefazolin sodium, 500 mg <1% 1,654 $737.84
93225 <1% 46 $689.63
70486 <1% 12 $682.00
82805 <1% 26 $678.16
J3010 Injection, fentanyl citrate, 0.1 mg <1% 3,287 $645.44
86617 <1% 24 $638.36
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,738 $633.94
87340 <1% 47 $630.96
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 495 $608.96
87205 <1% 288 $603.75
82330 <1% 74 $579.22
84550 <1% 102 $552.40
82150 <1% 145 $517.76
87081 <1% 140 $509.30
85014 <1% 234 $486.28
88342 <1% 28 $481.51
83970 <1% 13 $475.06
84520 <1% 108 $467.35
85018 <1% 217 $463.11
88313 <1% 25 $453.20
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 3,102 $453.10
84450 <1% 70 $448.09
76942 <1% 224 $435.72
86706 <1% 33 $418.91
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 15 $393.94
84460 <1% 65 $388.94
72072 <1% 24 $379.65
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 852 $377.70
87430 <1% 78 $373.05
J1644 Injection, heparin sodium, per 1000 units <1% 1,436 $354.85
80329 <1% 24 $337.69
93296 <1% 25 $328.23
J3535 Drug administered through a metered dose inhaler <1% 57 $302.75
88304 <1% 164 $299.26
73590 <1% 29 $294.12
96415 <1% 13 $293.90
J8501 Aprepitant, oral, 5 mg <1% 13 $266.24
73080 <1% 29 $263.85
86431 <1% 31 $223.79
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 56 $211.25
J0694 Injection, cefoxitin sodium, 1 gm <1% 35 $201.66
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 961 $173.77
82570 <1% 28 $168.55
J0780 Injection, prochlorperazine, up to 10 mg <1% 449 $167.43
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 1,576 $152.50
97162 <1% 12 $137.94
86592 <1% 30 $124.44
88307 <1% 82 $116.50
73090 <1% 14 $112.71
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 149 $107.38
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 2,854 $106.00
J7050 Infusion, normal saline solution, 250 cc <1% 968 $96.30
86376 <1% 12 $88.82
96376 <1% 97 $87.13
J2270 Injection, morphine sulfate, up to 10 mg <1% 180 $82.67
73562 <1% 15 $80.10
73140 <1% 14 $76.40
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 733 $74.78
36415 Collection of venous blood by venipuncture <1% 721 $69.86
97161 <1% 17 $67.97
97165 <1% 15 $67.90
86308 <1% 14 $64.24
84156 <1% 15 $64.08
J2704 Injection, propofol, 10 mg <1% 2,898 $52.91
J3370 Injection, vancomycin hcl, 500 mg <1% 28 $52.46
82947 <1% 27 $48.00
J2060 Injection, lorazepam, 2 mg <1% 464 $46.87
J3480 Injection, potassium chloride, per 2 meq <1% 78 $30.50
S0028 Injection, famotidine, 20 mg <1% 172 $10.82
94761 <1% 15 $9.87
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 398 $9.09
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 366 $6.58
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 41 $3.56
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 32 $0.84
S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) 0% 165 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 128 $0.00
J3475 Injection, magnesium sulfate, per 500 mg 0% 32 $0.00
76937 0% 12 $0.00
S0077 Injection, clindamycin phosphate, 300 mg 0% 16 $0.00
J0131 Injection, acetaminophen, not otherwise specified,10 mg 0% 959 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 0% 289 $0.00
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml 0% 336 $0.00
J7999 Compounded drug, not otherwise classified 0% 1,000 $0.00
J1030 Injection, methylprednisolone acetate, 40 mg 0% 41 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 12 $0.00
99153 Mod sedat endo service >5yrs 0% 13 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 12 $0.00
J1010 Injection, methylprednisolone acetate, 1 mg 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHILL, NAFIS (CFO)
Same official

Other billing entities under HILL, NAFIS

Full network →
ProviderLocationPaid
Upmc PassavantPittsburgh, PA$465.78

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.